BBC StoryWorks: A MedTech Europe Documentary Style Short Film
Hear from a NAFLD patient and clinical experts about how the ELF Test has the ability to improve outcomes for patients and transform systems of care.
ELF Featured in the News
ELF Helps NHS Tayside Reduce Liver Clinic Waiting List by Almost Half
Find out how NHS Tayside uses the ELF Test to help identify priority patients at risk.3
A Novel Two-step Pathway to Detect Liver Cirrhosis Earlier
Camden and Islington are two working class cities in the UK with an estimated NAFLD prevalence of 20%-30%. To reduce the burden of unnecessary referrals and improve detection of advanced liver disease, a “NAFLD pathway” was developed comprised of testing first with FIB-4 and reflexing indeterminate results to ELF. After 2 years the pathway data was compared to the Standard of Care.4,5
Hear From the Expert:
The Two Step Pathway Using Non-invasive Tests
The Two Step Pathway Using Non-invasive Tests
ELF Test identified as an important component of NAFLD clinical practice guidelines by the Chronic Liver Disease Foundation (CLDF)6
A small expert panel of hepatologists was tasked with creating straight-forward guidelines subsequent to the 2019 CLDF leadership forum. ELF plays a central role in the staging algorithm, and is the only proprietary serum fibrosis marker recommended by the expert panel.
